Conference item
Comparative cardiovascular safety of strontium ranelate and bisphosphonates amongst patients with no contraindications: A multi‐database study in 5 EU countries by the EU‐ADR Alliance
- Publication status:
- Published
- Peer review status:
- Reviewed (other)
Actions
Access Document
- Files:
-
-
(Preview, Accepted manuscript, pdf, 228.4KB, Terms of use)
-
- Publisher copy:
- 10.1002/pds.4629
Authors
- Publisher:
- Wiley
- Host title:
- Pharmacoepidemiology and Drug Safety
- Journal:
- Pharmacoepidemiology and Drug Safety More from this journal
- Volume:
- 27
- Issue:
- S2
- Pages:
- 161
- Publication date:
- 2018-08-17
- Acceptance date:
- 2018-05-08
- DOI:
- EISSN:
-
1099-1557
- ISSN:
-
1053-8569
- Pubs id:
-
pubs:920475
- UUID:
-
uuid:88a04819-391f-4cae-afe1-aec5946b6fb3
- Local pid:
-
pubs:920475
- Source identifiers:
-
920475
- Deposit date:
-
2019-03-27
Terms of use
- Copyright holder:
- Ali et al
- Copyright date:
- 2018
- Notes:
- © 2018 The Authors. Pharmacoepidimeology and Drug Safety © 2018 John Wiley & Sons, Ltd. This paper was presented at the 34th International Conference on Pharmacoepidemiology and Therapeutic Risk Management (ICPE 2018), 22-26 August 2018, Prague, Czech Republic. This is the accepted manuscript version of the article. The final version is available online from Wiley at: https://doi.org/10.1002/pds.4629
If you are the owner of this record, you can report an update to it here: Report update to this record